Founded in 1995 as a non-profit foundation, IrsiCaixa collaborates with healthcare professionals, patients, and community representatives to develop innovative solutions towards eradicating HIV infection. Their research focuses on multiple strategic lines, including vaccine and antibody development, clinical trials for novel therapeutic strategies, and global cooperation with low-income countries in the fight against the pandemic.